NEWBURY GROUP PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: F86060 | ILFORD, IG2 7LE
Showing results 101-150 of 626
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Phenoxymethylpenicillin (Penicillin V) | 461 | 52.5K | £2.0K | +50.4% ▲ |
| Fluticasone propionate (Inhalation) | 445 | 595 | £12.8K | +15.0% ▲ |
| Methotrexate | 435 | 7,656 | £4.2K | +33.6% ▲ |
| Nicorandil | 433 | 11.4K | £1.8K | +200.8% ▲ |
| Mesalazine (Systemic) | 422 | 45.2K | £24.8K | +76.2% ▲ |
| Clobetasone butyrate | 415 | 22.7K | £3.5K | +103.3% ▲ |
| Docusate sodium | 414 | 22.7K | £1.6K | +11.7% ▲ |
| Fluoxetine hydrochloride | 406 | 14.9K | £658 | -60.0% ▼ |
| Tramadol hydrochloride | 399 | 34.0K | £2.1K | -44.3% ▼ |
| Quinine sulfate | 397 | 6,993 | £1.2K | +37.1% ▲ |
| Insulin aspart | 394 | 2,714 | £16.9K | +3.5% ▲ |
| Loratadine | 391 | 19.2K | £510 | +87.1% ▲ |
| Venlafaxine | 387 | 13.4K | £2.2K | -54.2% ▼ |
| Lercanidipine hydrochloride | 379 | 15.2K | £1.6K | -38.6% ▼ |
| Risperidone | 378 | 9,770 | £1.7K | +49.4% ▲ |
| Mometasone furoate | 376 | 452 | £3.5K | -6.3% ▼ |
| Esomeprazole | 372 | 20.9K | £2.5K | -8.1% ▼ |
| Digoxin | 371 | 6,065 | £477 | -2.0% ▼ |
| Pravastatin sodium | 365 | 16.2K | £763 | +12.4% ▲ |
| 358 | 21.3K | £2.9K | +345.0% ▲ | |
| Insulin glargine | 351 | 1,825 | £16.0K | +23.6% ▲ |
| Fluticasone furoate | 348 | 387 | £2.6K | +79.6% ▲ |
| Insulin detemir | 344 | 1,938 | £16.3K | +339.2% ▲ |
| Felodipine | 343 | 15.3K | £2.4K | -42.2% ▼ |
| Estradiol | 337 | 15.6K | £2.9K | -58.9% ▼ |
| Calcipotriol | 336 | 31.1K | £18.0K | +97.4% ▲ |
| Lamotrigine | 333 | 20.6K | £3.0K | -43.6% ▼ |
| Fluticasone propionate (Nasal) | 328 | 1,075 | £4.5K | +125.3% ▲ |
| Buprenorphine | 327 | 1,838 | £4.8K | -10.7% ▼ |
| Other multivitamin preparations | 327 | 8,292 | £1.6K | +89.2% ▲ |
| Diltiazem hydrochloride | 324 | 19.2K | £3.3K | +5.5% ▲ |
| Semaglutide | 323 | 12.2K | £38.6K | +34.1% ▲ |
| 322 | 336 | £1.8K | +36.3% ▲ | |
| Procyclidine hydrochloride | 318 | 9,515 | £387 | +124.8% ▲ |
| 318 | 3,021 | £1.6K | +27.4% ▲ | |
| Enalapril maleate | 315 | 11.9K | £647 | +75.3% ▲ |
| Ranolazine | 310 | 8,908 | £1.7K | +82.4% ▲ |
| Betamethasone esters | 304 | 16.6K | £2.4K | +403.9% ▲ |
| Doxycycline hyclate | 294 | 5,851 | £550 | -42.6% ▼ |
| Biphasic insulin aspart | 289 | 2,338 | £14.0K | +184.6% ▲ |
| Sumatriptan succinate | 286 | 2,828 | £8.3K | -19.2% ▼ |
| Letrozole | 285 | 7,637 | £701 | +52.6% ▲ |
| Tacrolimus | 274 | 13.7K | £10.8K | +408.1% ▲ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 273 | 307 | £4.3K | +140.7% ▲ |
| Trimethoprim | 271 | 6,088 | £347 | +32.6% ▲ |
| Carbomer 940/980 | 265 | 6,030 | £1.4K | +74.0% ▲ |
| Moxonidine | 261 | 13.6K | £2.1K | +368.8% ▲ |
| Duloxetine hydrochloride | 259 | 7,056 | £1.5K | +405.4% ▲ |
| Mebeverine hydrochloride | 258 | 20.5K | £669 | -16.9% ▼ |
| Perindopril erbumine | 256 | 12.7K | £1.1K | -51.8% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.